“Two-Birds-One-Stone” Oral Nanotherapeutic Designed to Target Intestinal Integrins and Regulate Redox Homeostasis for Ulcerative Colitis Treatment
Preprint
Abstract
Designing highly efficient orally administrated nanotherapeutics with specific inflammatory site-targeting functions in the gastrointestinal (GI) tract for ulcerative colitis (UC) management is a significant challenge. Straightforward and adaptable modular multifunctional nanotherapeutics represent groundbreaking advancements and are crucial to promoting broad application in both academic research and clinical practice. In this study, we focused on exploring a specific targeting modular and functional oral nanotherapy, serving as “one stone”, for the directed localization of inflammation and the regulation of redox homeostasis, thereby achieving effects against “two birds” for UC treatment. The designed nanotherapeutic agent OPNs@LMWH, which has a core-shell structure composed of oxidation-sensitive ε-polylysine nanoparticles (OPNs) in the core and low-molecular-weight heparin (LMWH) in the shell, exhibited specific active targeting effects and therapeutic efficacy simultaneously. We qualitatively and quantificationally confirmed that OPNs@LMWH possessed high integrin αM-mediated immune cellular uptake efficiency and preferentially accumulated in inflamed lesions. Compared with bare OPNs, OPNs@LMWH exhibited enhanced intracellular reactive oxygen species (ROS) scavenging and anti-inflammatory effects. After oral administration of OPNs@LMWH to mice with dextran sulfate sodium (DSS)-induced colitis, robust resilience was observed. OPNs@LMWH effectively ameliorated oxidative stress and inhibited the activation of inflammation-associated signalling pathways while simultaneously bolstering the protective mechanisms of the colonic epithelium. Overall, these findings underscore the compelling dual functionalities of OPNs@LMWH, which enable effective oral delivery to inflamed sites, thereby facilitating precise UC management.Keywords
This publication has 46 references indexed in Scilit:
- Probiotic‐Inspired Nanomedicine Restores Intestinal Homeostasis in Colitis by Regulating Redox Balance, Immune Responses, and the Gut MicrobiomeAdvanced Materials, 2022
- Clinical translation of advanced colonic drug delivery technologiesAdvanced Drug Delivery Reviews, 2022
- Oral Delivery of Biologics for Precision MedicineAdvanced Materials, 2019
- Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectivesAdvanced Drug Delivery Reviews, 2019
- pH and Reactive Oxygen Species‐Sequential Responsive Nano‐in‐Micro Composite for Targeted Therapy of Inflammatory Bowel DiseaseAdvanced Functional Materials, 2018
- Evidence-based clinical practice guidelines for inflammatory bowel diseaseJournal of Gastroenterology, 2018
- Controllable production of low molecular weight heparins by combinations of heparinase I/II/IIICarbohydrate Polymers, 2014
- Adverse effects of biologics used for treating IBDBest Practice & Research Clinical Gastroenterology, 2010
- World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010Inflammatory Bowel Diseases, 2010
- The gastrointestinal tract stem cell nicheStem Cell Reviews, 2006